Ca 15.3
Sample Type | - |
Pre-test Information | - |
Report Delivery | - |
₹ Price | ₹ 1500 |
Frequently Asked Questions (FAQs)
CA 15.3 test uses two monoclonal antibodies (115D8 and DF3) which react with a circulating CA 15.3 antigen expressed in human breast cancer cell CA 15.3 test is used for the monitoring of therapy and disease progression for patients with diagnosed malignant tumors A decrease in the CA 15.3 concentration can indicate a positive response to therapy and therefore good prognosis. A constant increase in CA 15.3 concentration often reflects evolution of the tumor and a poor response to therapy Results from this test should be interpreted as part of a complete clinical profile and in conjunction with other diagnostic techniques CA 15.3 assay cannot be used as a screening test for cancer